Evidence map›Paper›PMID 23935835›Full record

ArticlePloS one2013

Preconditioning with associated blocking of Ca2+ inflow alleviates hypoxia-induced damage to pancreatic β-cells.

Zuheng Ma, Noah Moruzzi, Sergiu-Bogdan Catrina, Ingrid Hals, José Oberholzer, Valdemar Grill, Anneli Björklund

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 26 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Encapsulated Islet Transplantation: Where Do We Stand?The review of diabetic studies : RDS · 2017
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Zuheng MaDepartment of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.
Noah Moruzzi
Sergiu-Bogdan Catrina
Ingrid Hals
José Oberholzer
Valdemar Grill
Anneli Björklund
Karolinska Institutet · SENorwegian University of Science and Technology · NOSt Olav's University Hospital · NOUniversity of Illinois Chicago · US

Funding

Beta Cell Specific Microfluidic Perifusion and Imaging for Islet Potency TestingR01DK091526 · NIDDK · UNIVERSITY OF ILLINOIS AT CHICAGO · PI OBERHOLZER, JOSE · 2011 to 2015
$1.7M
NIDDK NIH HHS R01 DK091526NIDDK NIH HHS R01DK091526NLM NIH HHS HHSN276200900006C
6 · The paper itself

Abstract

objectiveBeta cells of pancreatic islets are susceptible to functional deficits and damage by hypoxia. Here we aimed to characterize such effects and to test for and pharmacological means to alleviate a negative impact of hypoxia. METHODS AND

designRat and human pancreatic islets were subjected to 5.5 h of hypoxia after which functional and viability parameters were measured subsequent to the hypoxic period and/or following a 22 h re-oxygenation period. Preconditioning with diazoxide or other agents was usually done during a 22 h period prior to hypoxia.

resultsInsulin contents decreased by 23% after 5.5 h of hypoxia and by 61% after a re-oxygenation period. Preconditioning with diazoxide time-dependently alleviated these hypoxia effects in rat and human islets. Hypoxia reduced proinsulin biosynthesis ((3)H-leucine incorporation into proinsulin) by 35%. Preconditioning counteracted this decrease by 91%. Preconditioning reduced hypoxia-induced necrosis by 40%, attenuated lowering of proteins of mitochondrial complexes I-IV and enhanced stimulation of HIF-1-alpha and phosphorylated AMPK proteins. Preconditioning by diazoxide was abolished by co-exposure to tolbutamide or elevated potassium (i.e. conditions which increase Ca(2+) inflow). Preconditioning with nifedipine, a calcium channel blocker, partly reproduced effects of diazoxide. Both diazoxide and nifedipine moderately reduced basal glucose oxidation whereas glucose-induced oxygen consumption (tested with diazoxide) was unaffected. Preconditioning with diaxoxide enhanced insulin contents in transplants of rat islets to non-diabetic rats and lowered hyperglycemia vs. non-preconditioned islets in streptozotocin-diabetic rats. Preconditioning of human islet transplants lowered hyperglycemia in streptozotocin-diabetic nude mice.

conclusions1) Prior blocking of Ca(2+) inflow associates with lesser hypoxia-induced damage, 2) preconditioning affects basal mitochondrial metabolism and accelerates activation of hypoxia-reactive and potentially protective factors, 3) results indicate that preconditioning by K(+)-ATP-channel openers has therapeutic potential for islet transplantations.

Indexed as

AMP-Activated Protein KinasesAnimalsCalciumCalcium Channel BlockersCell HypoxiaCells, CulturedDiabetes Mellitus, ExperimentalDiazoxideElectron Transport Chain Complex ProteinsHumansHypoglycemic AgentsHypoxia-Inducible Factor 1, alpha SubunitInsulinInsulin-Secreting CellsMaleMiceAMP-Activated Protein KinasesCalciumCalcium Channel BlockersDiazoxideElectron Transport Chain Complex ProteinsHIF1A protein, humanHypoglycemic AgentsHypoxia-Inducible Factor 1, alpha SubunitInsulinNifedipineOxygenPotassiumProinsulinStreptozocinTolbutamide

Identifiers

PMID23935835
PMCPMC3723782
OpenAlexW2106250573

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.